We performed co-immunoprecipitation (co-IP) experiments of LPXN in parental and midostaurin-resistant AML cells, as well as in FLT3-wildtype cells with high LPXN expression (OCI-AML3) and analyzed LPXN-interacting proteins by mass spectrometry. The gene discussed is RUNX2; the disease is acute myeloid leukemia.